Vertex Pharmaceuticals

FDA decision on Vertex's CF triple will come just ahead of planned CEO shakeup
FDA decision on Vertex's CF triple will come just ahead of planned CEO shakeup
Endpoints
Vertex Pharmaceuticals
FDA
cystic fibrosis
VX-445
tezacaftor/ivacaftor
Flag link:
What happened a year ago this week in biopharma? August 12-18, 2018
Regeneron
Novartis
wet-AMD
Eylea
ethics
Vertex Pharmaceuticals
Kalydeco
cystic fibrosis
Bristol-Myers Squibb
Opdivo
Merck
Keytruda
SCLC
Flag link:
What happened a year ago this week in biopharma? August 12-18, 2018
What happened a year ago this week in biopharma? August 12-18, 2018
CP WIre
Regeneron
Novartis
wet-AMD
Eylea
ethics
Vertex Pharmaceuticals
Kalydeco
cystic fibrosis
Bristol-Myers Squibb
Opdivo
Merck
Keytruda
SCLC
Flag link:
As negotiations with England labor on, Scotland rejects routine use of Vertex's cystic fibrosis drugs
As negotiations with England labor on, Scotland rejects routine use of Vertex's cystic fibrosis drugs
Endpoints
Vertex Pharmaceuticals
UK
Scotland
cystic fibrosis
Flag link:
Will This Asteroid Heading Toward Vertex Pharmaceuticals Make Impact?
Will This Asteroid Heading Toward Vertex Pharmaceuticals Make Impact?
Motley Fool
Vertex Pharmaceuticals
cystic fibrosis
Translate Bio
MRT5005
Flag link:
Vertex expects more, perhaps bigger M&A to come
Vertex expects more, perhaps bigger M&A to come
Biopharma Dive
Vertex Pharmaceuticals
M&A
Flag link:
Vertex’s CF ‘firepower’ to fund more deals, broader pipeline
Vertex’s CF ‘firepower’ to fund more deals, broader pipeline
BioCentury
Vertex Pharmaceuticals
cystic fibrosis
Flag link:
Vertex's planned CEO handoff could signal stagnant growth to come: analyst
Vertex's planned CEO handoff could signal stagnant growth to come: analyst
Fierce Pharma
Vertex Pharmaceuticals
Jeff Leiden
Reshma Kewalramani
Pharma CEOs
Flag link:
Vertex Pharmaceuticals’ Jeffrey Leiden to step aside as CEO
Vertex Pharmaceuticals’ Jeffrey Leiden to step aside as CEO
Stat
Vertex Pharmaceuticals
Pharma CEOs
Reshma Kewalramani
Jeffrey Leiden
Flag link:
Vertex files cystic fibrosis triple therapy with FDA
Vertex files cystic fibrosis triple therapy with FDA
PM Live
Vertex Pharmaceuticals
FDA
cystic fibrosis
VX-445
Flag link:
The Week Ahead In Biotech: Pending Clinical Readouts In Focus
The Week Ahead In Biotech: Pending Clinical Readouts In Focus
Yahoo/Benzinga
Retrophin
Karyopharm
Celyad
uniQure
Sangamo Therapeutics
Catalyst Biosciences
Novo Nordisk
Reata Pharmaceuticals
Vertex Pharmaceuticals
Bellicum
Gilead Sciences
Jaguar Health
TRACON Pharmaceuticals
FibroGen
Aslan Pharma
ObsEva
Sorrento Therapeutics
Flag link:
3 Big Biotechs Hold Growth Potential in Second Half of 2019
3 Big Biotechs Hold Growth Potential in Second Half of 2019
Yahoo/Zacks.com
Alexion
Gilead Sciences
Vertex Pharmaceuticals
Flag link:
5 Most Valuable Pipeline Drugs in Development -- and the Stocks Poised to Profit
5 Most Valuable Pipeline Drugs in Development -- and the Stocks Poised to Profit
Motley Fool
Vertex Pharmaceuticals
VX-445
tezacaftor/ivacaftor
AbbVie
upadacatinib
Daiichi Sankyo
trastuzumab deruxtecan
Celgene
liso-cel
Novartis
LY3298176
Flag link:
Gene Therapy vs. Gene Editing: Which Is Better for Tackling Muscular Dystrophy?
Gene Therapy vs. Gene Editing: Which Is Better for Tackling Muscular Dystrophy?
Motley Fool
gene editing
gene therapy
DMD
Duchenne Muscular Dystrophy
Vertex Pharmaceuticals
CRISPR Therapeutics
Exonics
Flag link:
Vertex sets sights on DMD gene therapy, joining crowded field
Vertex sets sights on DMD gene therapy, joining crowded field
Biopharma Dive
Vertex Pharmaceuticals
DMD
M&A
CRISPR Therapeutics
Exonics
gene therapy
Flag link:
Orkambi parents start ‘buyers club’ to import generic version of CF drug
Orkambi parents start ‘buyers club’ to import generic version of CF drug
Pharmaforum
cystic fibrosis
patients
UK
Orkambi
Vertex Pharmaceuticals
Flag link:
Vertex to submit VX-445, Tezacaftor and Ivacaftor regimen for global regulatory approvals in cystic fibrosis
Vertex to submit VX-445, Tezacaftor and Ivacaftor regimen for global regulatory approvals in cystic fibrosis
Pharmaceutical Business Review
Vertex Pharmaceuticals
VX-445
tezacaftor
ivacaftor
cystic fibrosis
Flag link:
Biotech Companies Provide High Median Salaries, Analysis Shows
Biotech Companies Provide High Median Salaries, Analysis Shows
BioSpace
salaries
biotech
Incyte
Celgene
Vertex Pharmaceuticals
Flag link:
Fired for code of conduct violations, Ian Smith still grabbed a multimillion-dollar stock package at Vertex — but the cash bonus was axed
Fired for code of conduct violations, Ian Smith still grabbed a multimillion-dollar stock package at Vertex — but the cash bonus was axed
Endpoints
Vertex Pharmaceuticals
Ian Smith
exective pay
Flag link:
Investors to AbbVie, J&J, Merck and more: Fork over info on pricing and executive pay
Investors to AbbVie, J&J, Merck and more: Fork over info on pricing and executive pay
Fierce Pharma
AbbVie
Celgene
JNJ
Merck
Pfizer
Vertex Pharmaceuticals
investors
executive pay
Flag link:

Pages